🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hypersensitivity Reactions

Effect of Fluoride Varnish Formulation on the Management of Dentin Hypersensitivity NCT07286344NA1 site📍 Concepción University of Concepcion, Chile · Tests: Aqueous fluoride varnish, 9,500 ppm NaF, Resin/rosin-based varnish, 22,600 ppm NaF A Randomized Multicenter Study for Isolated Skin Vasculitis NCT02939573Phase 216 sites📍 Kansas City📍 Boston📍 Rochester University of Pennsylvania · Tests: Colchicine, Dapsone, Azathioprine A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) NCT07355075Phase 2, Phase 31 site📍 Irving Turn Therapeutics · Tests: GX-03, Vehicle Direct Oral Challenges in Private Practice Setting to Delabeling Children With Beta-lactam Allergy NCT07002814n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris APP-based Medical Device for Education and Training of Inhalation Technique NCT07145632NA3 sites📍 Uppsala📍 Styrsö📍 Boxholm Karolinska Institutet · Tests: App-based education and training of inhalation technique Effect of Omalizumab in the Skin of Food Allergy Patients NCT06618963Phase 41 site📍 Denver National Jewish Health · Tests: Omalizumab Injection Multi-modal Quantitative Imaging of the Skin NCT06989216n/a3 sites📍 Stockholm📍 Stockholm📍 Stockholm HJN Sverige AB/Neko Health Sensory Symptoms in Tourette Syndrome NCT03851484n/a2 sites📍 Nashville📍 Nashville Vanderbilt University Medical Center Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus Complete NCT07444008NA1 site📍 Saint Petersburg NovoNatum Ltd · Tests: BioAmicus Complete, Placebo To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong NCT04639791n/a1 site📍 Shatin Chinese University of Hong Kong · Tests: No intervention Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis NCT04815668NA1 site📍 Beijing Guang'anmen Hospital of China Academy of Chinese Medical Sc… · Tests: Acupuncture group, Placebo acupuncture group, Rescue medication group Pathway to Peanut Tolerance NCT07592780NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Peanut Oral Immunotherapy (OIT) Hypersensitivity to Adrenomedullin in Post-Traumatic Headache NCT07059546NA1 site📍 Glostrup Municipality Danish Headache Center · Tests: Adrenomedullin, Placebo Neurological Responses in Patients with Dentine Hypersensitivity NCT06633627n/a1 site📍 Sheffield Sheffield Teaching Hospitals NHS Foundation Trust · Tests: Recording of brain activity using electroencephalography (EEG) OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages NCT02523118n/a19 sites📍 Phoenix📍 Rogers📍 San Diego Children's Hospital Medical Center, Cincinnati Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room NCT05420935NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: IgG group, IgE group, IgG group + IgE group Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis NCT06801821n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Deep Phenotyping of CIndU NCT07359430n/a3 sites📍 Leiden📍 Rotterdam📍 Utrecht Centre for Human Drug Research, Netherlands Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome NCT07242638Phase 21 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Abrocitinib Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders NCT00267501n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati Frequency of Palpebral Involvement in Adult With Atopic Dermatitis NCT04826744n/a2 sites📍 Lille📍 Rouen University Hospital, Lille · Tests: Standard dermatology consultation Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population NCT07614633n/a2 sites📍 Pavia📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Remote Anxiety Management for ICS-resistant Asthma Study NCT06732141NA11 sites📍 Harbin📍 Hefei📍 Hefei First Affiliated Hospital of Ningbo University · Tests: Personalized Telephone-Based Psychological Support, Standard Care with Weekly Follow-Up Calls Infant Formula in Infants and Children With Cow's Milk Allergy NCT06456541NA9 sites📍 Phoenix📍 Aurora📍 Chicago Abbott Nutrition · Tests: Experimental Extensively Hydrolyzed Formula, Placebo Extensively Hydrolyzed Formula A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients NCT06946641Phase 11 site📍 Beijing Shanghai Qilu Pharmaceutical Research and Development Cente… · Tests: QLS12010, Placebo Mediterranean and Low-Histamine Diets for Pediatric Chronic Spontaneous Urticaria NCT07765979NA1 site📍 Istanbul Saglik Bilimleri Universitesi · Tests: Low-Histamine Diet, Mediterranean Diet Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome NCT05444946NA2 sites📍 Chandigarh📍 Chandigarh Post Graduate Institute of Medical Education and Research, … · Tests: Prednisone tablet and Itraconazole, Oral itraconazole Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab NCT07363642Phase 375 sites📍 Beijing📍 Beijing📍 Beijing AstraZeneca · Tests: Tezepelumab Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis NCT07298395Phase 232 sites📍 Birmingham📍 Hot Springs📍 Beverly Hills Enveda Therapeutics · Tests: ENV-294, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy